TMCnet News

Research and Markets: Glaucoma - Pipeline Review, H1 2013
[April 24, 2013]

Research and Markets: Glaucoma - Pipeline Review, H1 2013


DUBLIN --(Business Wire)--

Research and Markets has announced the addition of the "Glaucoma - Pipeline Review, H1 2013" report to their offering.

'Glaucoma - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Glaucoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Glaucoma.

Scope

- A snapshot of the global therapeutic scenario for Glaucoma.

- A review of the Glaucoma products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based onvarious stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Glaucoma pipeline on the basis of route of administration and molecule type.


- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Companies Involved in Glaucoma Therapeutics Development

  • AC Immune SA
  • ACADIA Pharmaceuticals Inc.
  • Advanced Cell Technology, Inc.
  • Aerie Pharmaceuticals, Inc.
  • Alcon, Inc.
  • Allergan, Inc.
  • Altacor Ltd.
  • Can-Fite BioPharma Ltd.
  • CeNeRx BioPharma, Inc.
  • Ceregene, Inc.
  • Colby Pharmaceutical Company
  • ISTA Pharmaceuticals, Inc.
  • Icon Bioscience, Inc.
  • InSite Vision Incorporated
  • Intellect (News - Alert) Neurosciences, Inc.
  • Kowa Company, Ltd.
  • LABORATOIRES THEA
  • Lacer, S.A.
  • Merz GmbH & Co. KGaA
  • Neurotech Pharmaceuticals, Inc.
  • Ono Pharmaceutical Co., Ltd.
  • Oxford BioMedica plc
  • PharmaNova Inc.
  • Phytopharm Plc
  • Proneuron Biotechnologies, Inc.
  • Proximagen Neuroscience plc.
  • Quark Pharmaceuticals, Inc.
  • SIFI Pharma
  • Santen Pharmaceutical Co., Ltd.
  • Sylentis

For more information visit Research and Markets


[ Back To TMCnet.com's Homepage ]